GE HealthCare Technologies (GEHC) Gains from Investment Securities (2022 - 2024)
GE HealthCare Technologies' (GEHC) quarterly Gains from Investment Securities came in at -$9.0 million in Q3 2024, up 35.71% YoY from -$6.6 million in Q4 2023, and little changed on a QoQ basis from -$9.0 million in Q2 2024.
GE HealthCare Technologies (GEHC) Gains from Investment Securities (2022 - 2024) Analysis & Trends
GE HealthCare Technologies (GEHC) has 3 years of Gains from Investment Securities data on file, last reported at -$9.0 million in Q3 2024.
- Quarterly Gains from Investment Securities rose 35.71% year-over-year to -$9.0 million in Q3 2024, while the trailing twelve-month figure through Dec 2024 was -$19.0 million (down 11.76% YoY) and the FY2024 annual result came in at -$19.0 million, down 11.76% from the prior year.
- Gains from Investment Securities was little changed at -$9.0 million in Q3 2024, from -$9.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of -$1.0 million in Q1 2024 to a low of -$49.0 million in Q3 2022.
- A 3-year average of -$14.4 million and a median of -$9.0 million in 2024 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities soared 71.43% — and 2024, when it sank 200.0%.
- Tracing GEHC's Gains from Investment Securities over 3 years: stood at -$16.0 million in 2022, then increased by 12.5% to -$14.0 million in 2023, then jumped by 35.71% to -$9.0 million in 2024.
- The last three Gains from Investment Securities figures came in at -$9.0 million (Q3 2024), -$9.0 million (Q2 2024), and -$1.0 million (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -9.00 Mn |
| Sep 30, 2024 | -9.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Mar 31, 2024 | -1.00 Mn |
| Mar 31, 2024 | -1.00 Mn |
| Sep 30, 2023 | -14.00 Mn |
| Sep 30, 2023 | -14.00 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Dec 31, 2022 | -16.00 Mn |
| Dec 31, 2022 | -16.00 Mn |
| Sep 30, 2022 | -49.00 Mn |
| Sep 30, 2022 | -49.00 Mn |